CollPlant Biotechnologies (CLGN) EBITDA Margin (QoQ) (2018 - 2025)
CollPlant Biotechnologies (CLGN) EBITDA Margin (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -69,545.00 |
| Sep 30, 2025 | -632,996.00 |
| Jun 30, 2025 | 169,522.00 |
| Mar 31, 2025 | 250,337.00 |
| Dec 31, 2024 | 11.11 Mn |
| Sep 30, 2024 | -11.53 Mn |
| Jun 30, 2024 | -264,787.00 |
| Mar 31, 2024 | 611,233.00 |
| Dec 31, 2023 | -169,497.00 |
| Sep 30, 2023 | -5,576.00 |
| Jun 30, 2023 | -75,696.00 |
| Mar 31, 2023 | 887,477.00 |
| Dec 31, 2022 | -396,299.00 |
| Sep 30, 2022 | 224,183.00 |
| Dec 31, 2021 | 98,290.00 |
| Sep 30, 2021 | -176,673.00 |
| Jun 30, 2021 | -51,242.00 |
| Mar 31, 2021 | 16,041.00 |
| Dec 31, 2020 | -10,896.00 |
| Sep 30, 2020 | 25,014.00 |